F Dehdashti

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi Assessment of cellular proliferation in tumors by PET using 18F-ISO-1
    Farrokh Dehdashti
    Division of Nuclear Medicine and Radiological Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Nucl Med 54:350-7. 2013
  2. ncbi Positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study
    Farrokh Dehdashti
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    Mol Imaging Biol 15:106-13. 2013
  3. ncbi Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione
    Farrokh Dehdashti
    Divisions of Nuclear Medicine and Radiological Sciences, Edward Mallinckrodt Institute of Radiology, St Louis, MO, USA
    J Nucl Med 53:363-70. 2012
  4. ncbi Positron tomographic assessment of androgen receptors in prostatic carcinoma
    Farrokh Dehdashti
    The Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, 63110, USA
    Eur J Nucl Med Mol Imaging 32:344-50. 2005
  5. ncbi In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
    Farrokh Dehdashti
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Eur J Nucl Med Mol Imaging 30:844-50. 2003
  6. ncbi Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone)
    Farrokh Dehdashti
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, St Louis, Missouri 63110, USA
    J Nucl Med 49:201-5. 2008
  7. ncbi PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer
    Farrokh Dehdashti
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Breast Cancer Res Treat 113:509-17. 2009
  8. ncbi A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy
    K S Chao
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University Medical Center, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 49:1171-82. 2001
  9. ncbi FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma
    Anurag K Singh
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 56:489-93. 2003
  10. ncbi Metabolic flare: indicator of hormone responsiveness in advanced breast cancer
    J E Mortimer
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    J Clin Oncol 19:2797-803. 2001

Collaborators

Detail Information

Publications66

  1. ncbi Assessment of cellular proliferation in tumors by PET using 18F-ISO-1
    Farrokh Dehdashti
    Division of Nuclear Medicine and Radiological Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Nucl Med 54:350-7. 2013
    ....
  2. ncbi Positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study
    Farrokh Dehdashti
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA
    Mol Imaging Biol 15:106-13. 2013
    ....
  3. ncbi Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione
    Farrokh Dehdashti
    Divisions of Nuclear Medicine and Radiological Sciences, Edward Mallinckrodt Institute of Radiology, St Louis, MO, USA
    J Nucl Med 53:363-70. 2012
    ....
  4. ncbi Positron tomographic assessment of androgen receptors in prostatic carcinoma
    Farrokh Dehdashti
    The Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, 63110, USA
    Eur J Nucl Med Mol Imaging 32:344-50. 2005
    ....
  5. ncbi In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
    Farrokh Dehdashti
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Eur J Nucl Med Mol Imaging 30:844-50. 2003
    ..04; P=0.9). (60)Cu-ATSM-PET can be readily performed in patients with NSCLC and the tumor uptake of (60)Cu-ATSM reveals clinically unique information about tumor oxygenation that is predictive of tumor response to therapy...
  6. ncbi Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone)
    Farrokh Dehdashti
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, St Louis, Missouri 63110, USA
    J Nucl Med 49:201-5. 2008
    ..9). Pretherapy (60)Cu-ATSM PET provides clinically relevant information about tumor oxygenation that is predictive of outcome in patients with cervical cancer...
  7. ncbi PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer
    Farrokh Dehdashti
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Breast Cancer Res Treat 113:509-17. 2009
    ....
  8. ncbi A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy
    K S Chao
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University Medical Center, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 49:1171-82. 2001
    ....
  9. ncbi FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma
    Anurag K Singh
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 56:489-93. 2003
    ..0005). CONCLUSION: The cause-specific survival for patients with FIGO Stage IIIb carcinoma is highly dependent on the extent of lymph node metastasis as demonstrated by whole-body FDG-PET...
  10. ncbi Metabolic flare: indicator of hormone responsiveness in advanced breast cancer
    J E Mortimer
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    J Clin Oncol 19:2797-803. 2001
    ..3%; P =.0003). CONCLUSION: The functional status of tumor ERs can be characterized in vivo by PET with FDG and FES. The results of PET are predictive of responsiveness to tamoxifen therapy in patients with advanced ER(+) breast cancer...
  11. ncbi 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Kenneth J Biehl
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri, USA
    J Nucl Med 47:1808-12. 2006
    ....
  12. ncbi Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis
    Elizabeth A Kidd
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 4921 Parkview Place, Box 8224, St Louis, MO 63110, USA
    J Clin Oncol 28:2108-13. 2010
    ..27 (95% CI 16.56 to 55.34). CONCLUSION Nodal involvement detected by FDG-PET in cervical cancer relates to clinical stage, is comparable to historical data, and stratifies patient recurrence and survival outcomes...
  13. ncbi Posttherapy surveillance monitoring of cervical cancer by FDG-PET
    Perry W Grigsby
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 55:907-13. 2003
    ....
  14. ncbi Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study
    S M Strasberg
    Section of Hepatobiliary Pancreatic Surgery, Department of Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    Ann Surg 233:293-9. 2001
    ..To present the survival results for patients with colorectal carcinoma metastases who have undergone liver resection after being staged by [(18)F] fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)...
  15. ncbi FDG-PET evaluation of vaginal carcinoma
    Wayne T Lamoreaux
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 62:733-7. 2005
    ..The 3-year progression-free and overall survival estimate was 73% and 68%, respectively. CONCLUSION: The results of this study have demonstrated that FDG-PET detects the primary tumor and abnormal lymph nodes more often than does CT...
  16. ncbi The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
    Elizabeth A Kidd
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Cancer 110:1738-44. 2007
    ....
  17. ncbi Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer
    Julie K Schwarz
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 71:180-6. 2008
    ..To evaluate the response to therapy for anal carcinoma using post-therapy imaging with positron emission tomography (PET)/computed tomography and F-18 fluorodeoxyglucose (FDG) and to compare the metabolic response with patient outcome...
  18. ncbi Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer
    David E Cohn
    Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, Missouri, USA
    Gynecol Oncol 85:179-84. 2002
    ..We set out to determine the ability of positron emission tomography with fluorodeoxyglucose to detect groin lymph node metastases from vulvar cancer...
  19. ncbi 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse
    Nobuyuki Oyama
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Boulevard, St. Louis, MO 63110, USA
    J Nucl Med 44:549-55. 2003
    ..CONCLUSION: AC PET demonstrates marked uptake in prostate cancer and has higher sensitivity than (18)F-FDG PET. These preliminary data show that (11)C-acetate is a promising tracer for detection of recurrent prostate cancer...
  20. ncbi Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer
    Rebecca A Brooks
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 112:104-9. 2009
    ..To evaluate survival after detection of recurrent cervical cancer by FDG-PET in symptomatic versus asymptomatic patients...
  21. ncbi Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer
    Elizabeth A Kidd
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 77:1085-91. 2010
    ..This study aimed to evaluate the toxicity and clinical outcomes for cervical cancer patients treated definitively with intensity-modulated radiation therapy (IMRT) compared with non-IMRT treatment...
  22. ncbi Evaluation of breast and gynecologic cancers by positron emission tomography
    Farrokh Dehdashti
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Boulevard, St. Louis, MO 63110, USA
    Semin Roentgenol 37:151-68. 2002
  23. ncbi Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas
    F Dehdashti
    Division of Nuclear Medicine Edward Mallinckrodt Institute of Radiology, St Louis, MO 63110
    J Nucl Med 32:1532-7. 1991
    ..We noted a low target-to-background ratio in humans, with high relative activity in the spine, blood pool, and normal breast tissue. Our findings indicate that FENP is not a suitable agent for imaging progestin receptors in humans...
  24. ncbi Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix
    Binh N Tran
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, St. Louis, MO, USA
    Gynecol Oncol 90:572-6. 2003
    ..CONCLUSION: The positive predictive value of abnormal FDG uptake in left supraclavicular lymph nodes was 100%. Prognosis for these patients was dismal despite aggressive therapy...
  25. ncbi Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)
    Felix G Fernandez
    Section of Hepatobiliary-Pancreatic Surgery, Department of Surgery, Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA
    Ann Surg 240:438-47; discussion 447-50. 2004
    ..FDG-PET appears to define a new cohort of patients in whom tumor grade is a very important prognostic variable...
  26. ncbi Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer
    Neil S Horowitz
    Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 95:546-51. 2004
    ....
  27. ncbi Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer
    Elizabeth A Kidd
    Department of Radiation Oncology, Box 8224, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 4921 Parkview Place, St Louis, MO 63110, USA
    Cancer 116:1469-75. 2010
    ....
  28. ncbi Lymph node staging by positron emission tomography in patients with carcinoma of the cervix
    P W Grigsby
    Mallinckrodt Institute of Radiology and the Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA
    J Clin Oncol 19:3745-9. 2001
    ....
  29. ncbi F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy
    Feiyu Xue
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
    Gynecol Oncol 101:147-51. 2006
    ..High FDG uptake may be useful in identifying patients who may require more aggressive initial therapy...
  30. ncbi The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries
    Julie K Schwarz
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, St Louis, Missouri, USA
    J Nucl Med 50:64S-73S. 2009
    ....
  31. ncbi FDG-PET/CT in the evaluation of anal carcinoma
    Shane E Cotter
    Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA
    Int J Radiat Oncol Biol Phys 65:720-5. 2006
    ..FDG-PET/CT detects substantially more abnormal inguinal lymph nodes than are identified by standard clinical staging with CT and physical examination...
  32. ncbi Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET
    Steven E Finkelstein
    Section of Hepatobiliary Pancreatic Surgery, Washington University in St Louis and Barnes Jewish Hospital, St Louis, MO, USA
    J Hepatobiliary Pancreat Surg 15:483-7. 2008
    ..In this study, the site- and time-specific patterns of recurrence were examined in patients staged by FDG-PET and the results compared to historical literature control data...
  33. ncbi An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix
    Jason S Lewis
    Division of Radiological Sciences, Mallinckrodt Institute of Radiology, St Louis, Missouri, USA
    J Nucl Med 49:1177-82. 2008
    ....
  34. ncbi Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma
    Julie K Schwarz
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    JAMA 298:2289-95. 2007
    ..Retrospective studies have demonstrated that the use of positron emission tomography (PET) with F-18 fluorodeoxyglucose (FDG) in the posttherapy evaluation of patients with cervical carcinoma is predictive of survival outcome...
  35. ncbi Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report
    Farrokh Dehdashti
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 55:1233-8. 2003
    ..We have investigated whether pretreatment tumor hypoxia assessed by positron emission tomography (PET) with Cu-60 diacetyl-bis(N(4)-methylthiosemicarbazone) ((60)Cu-ATSM) predicts responsiveness to subsequent therapy in cervical cancer...
  36. ncbi Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer
    Steven M Strasberg
    Section of Hepato Pancreato Biliary Surgery, Department of Surgery, Washington University in St Louis, St Louis, MO, USA
    J Surg Oncol 102:955-9. 2010
    ..FDG-PET is highly sensitive and specific for intrahepatic colorectal tumors and the most sensitive test for extrahepatic tumors. FDG-PET alters management in 25% of patients, reducing futile laparotomies and hepatectomies...
  37. ncbi Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer
    Tom R Miller
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Nucl Med 44:192-7. 2003
    ..This study using PET with (18)F-FDG was undertaken to determine whether a simple and fast visual analysis of characteristics of the primary tumor before initiation of treatment could achieve this goal...
  38. ncbi Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET
    Sharlene A Teefey
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Blvd, St Louis, MO 63110, USA
    Radiology 226:533-42. 2003
    ....
  39. ncbi Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET
    Bartosz Rydzewski
    Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Blvd, St. Louis, MO 63110, USA
    AJR Am J Roentgenol 178:353-8. 2002
    ..Although intraoperative sonography helps to determine the anatomic location of metastases thus facilitating surgical resection, its adjunctive use in patients screened preoperatively by FDG PET has limited impact on treatment selection...
  40. ncbi Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma
    Adam S Kibel
    Division of Urologic Surgery, Washington University School of Medicine, 4960 Children s Place, Box 8242, St Louis, MO 63105, USA
    J Clin Oncol 27:4314-20. 2009
    ..Herein, we report a prospective study of positron emission tomography/computed tomography (PET/CT) with [(18)F]fluorodeoxyglucose (FDG) in patients undergoing radical cystectomy for cT2-3N0M0 urothelial carcinoma of the bladder...
  41. ncbi PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study
    Sasa Mutic
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 55:28-35. 2003
    ..CONCLUSION: This study indicates that PET-guided IMRT could be used in a clinical trial in an attempt to escalate doses delivered to patients with cervical cancer who have positive PALNs...
  42. ncbi Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis
    Amber L Traugott
    Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
    World J Surg 34:1247-53. 2010
    ..We now report results on the first 51 patients in the largest prospective study of FDG-PET in patients with an indeterminate thyroid nodule FNA...
  43. ncbi Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake
    Elizabeth A Kidd
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Cancer 115:3548-54. 2009
    ..This study aimed to evaluate the variation in cervical cancer glucose metabolism for different tumor histologies and levels of differentiation, as measured by the uptake of 18F-fluorodeoxyglucose (FDG) by positron emission tomography (PET)...
  44. ncbi Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix
    Perry W Grigsby
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Mol Imaging Biol 9:278-83. 2007
    ..To determine if hypoxia-related molecular markers are associated with (60)Cu labeled diacetyl-bis (N4 -methylthiosemicarbazone); ((60)Cu-ATSM) imaging of tumor hypoxia in cervical cancer...
  45. ncbi Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study
    Matthew J Ellis
    Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    JAMA 302:774-80. 2009
    ..Estrogen deprivation therapy with aromatase inhibitors has been hypothesized to paradoxically sensitize hormone-receptor-positive breast cancer tumor cells to low-dose estradiol therapy...
  46. ncbi Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results
    Barry A Siegel
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Nucl Med 44:700-7. 2003
    ..We report here the initial clinical study of such an agent, (111)In-diethylenetriaminepentaacetic acid (DTPA)-folate, evaluated for diagnosis of ovarian malignancy...
  47. ncbi Lymph node control in cervical cancer
    Perry W Grigsby
    Department of Radiation Oncology, and Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 59:706-12. 2004
    ..The aim was to evaluate pretreatment lymph node size, irradiation dose, and failure patterns...
  48. ncbi Neoplasms of the esophagus and stomach
    Farrokh Dehdashti
    Division of Nuclear Medicine, Edward Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA
    Semin Nucl Med 34:198-208. 2004
    ..Only a few published studies have evaluated gastric cancer with FDG-PET. These studies suggest that FDG-PET may be useful in evaluating gastric cancers of intestinal type and nonmucinous tumors...
  49. ncbi Positron emission tomography in limited-stage small-cell lung cancer: a prospective study
    Jeffrey D Bradley
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 4921 Parkview Place, St Louis, MO 63110, USA
    J Clin Oncol 22:3248-54. 2004
    ....
  50. ncbi Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET
    Perry W Grigsby
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 61:444-9. 2005
    ..To compare the outcome of patients with cervical cancer and negative lymph nodes by fluorodeoxyglucose-positron emission tomography (FDG-PET) treated with irradiation (RT) and concurrent chemotherapy or RT alone...
  51. ncbi Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome
    Perry W Grigsby
    Department of Radiation Oncology, Box 8224, Washington University School of Medicine, 4921 Parkview Pl, Lower Level, St Louis, MO 63110, USA
    J Clin Oncol 22:2167-71. 2004
    ..The aim of this study was to evaluate response to therapy using posttherapy molecular imaging with [(18)F] fluorodeoxyglucose (FDG), and to compare the response with patient outcome...
  52. ncbi Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET
    Richard Laforest
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, Campus Box 8225, 510 S Kingshighway, St Louis, MO 63110, USA
    Eur J Nucl Med Mol Imaging 32:764-70. 2005
    ..Dosimetry calculations by the established Medical Internal Radionuclide Dose (MIRD) approach were performed with both animal and patient data...
  53. ncbi Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer
    Jeffrey Bradley
    Department of Radiation Oncology, Mallinkrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 59:78-86. 2004
    ....
  54. ncbi Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes
    Jacqueline Esthappan
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 58:1289-97. 2004
    ..g., number of beams, beam geometry) and organ-specific parameters (e.g., importance weighting and tolerance dose) for intensity-modulated radiotherapy planning for the PALNs...
  55. ncbi Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine and Alvin J Siteman Cancer Center, St Louis, Missouri 63110, USA
    Cancer 104:2484-91. 2005
    ..The objective of this study was to determine the sensitivity and specificity of PET in detecting lymph node metastasis in women with early-stage cervical carcinoma...
  56. ncbi Advances in positron emission tomographic imaging of lung cancer
    Delphine L Chen
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Campus Box 8223, 510 S Kingshighway Boulevard, St Louis, MO 63110, USA
    Proc Am Thorac Soc 2:541-4, 512. 2005
    ..The role of PET will continue to evolve with further clinical studies using these and other new tracers...
  57. ncbi Oncologic PET/CT: current status and controversies
    Barry A Siegel
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 63110, USA
    Eur Radiol 15:D127-32. 2005
    ..There are a number of controversies related to PET/CT, including minimum training and experience requirements for interpreting physicians and defining new models for technical and professional reimbursement...
  58. ncbi Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer
    Steven E Finkelstein
    Department of Surgery, Washington University School of Medicine, St Louis, MO, USA
    Ann Surg Oncol 15:286-92. 2008
    ..Limited data are available regarding the performance of combined FDG-PET/computed tomography (FDG-PET/CT) for detecting recurrent thyroid cancer in WBS-neg patients...
  59. ncbi Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer
    Jeffrey D Bradley
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, St Louis, Missouri, USA
    J Nucl Med 45:96S-101S. 2004
    ..In this report, we will review the literature on PET-based radiation treatment planning, its potential benefits, and future challenges...
  60. ncbi The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial
    Bryan F Meyers
    Department of Surgery, Washington University School of Medicine, St Louis, MO
    J Thorac Cardiovasc Surg 133:738-45. 2007
    ....
  61. ncbi Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis
    Elizabeth A Kidd
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Radiother Oncol 95:288-91. 2010
    ..To evaluate anal cancer uptake of F-18 fluorodeoxyglucose (FDG) measured as the maximum standardized uptake value (SUV(max)) by positron emission tomography (PET) and its correlation with prognostic factors...
  62. ncbi FDG uptake in colonic villous adenomas
    Nuri Arslan
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
    Ann Nucl Med 19:331-4. 2005
    ..Future studies in a larger number of patients are needed to evaluate the relationship of histopathological features of colonic polyps and detectability of these lesions by FDG-PET...
  63. ncbi Correlation of severity of FDG-PET hypometabolism and interictal regional delta slowing in temporal lobe epilepsy
    Ebru Erbayat Altay
    Department of Neurology, Washington University in St Louis, School of Medicine, St Louis, Missouri 63110, USA
    Epilepsia 46:573-6. 2005
    ..46; p < 0.0005). CONCLUSIONS: This observation suggests related underlying pathophysiologic mechanisms for metabolic and electrical dysfunction in temporal lobe epilepsy...
  64. ncbi Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography
    M S Cohen
    Department of Surgery, The Siteman Cancer Center, and the Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Surgery 130:941-6. 2001
    ..Standardized uptake values may be helpful in predicting benign versus malignant histology...
  65. ncbi Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study
    David W Dietz
    Department of Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Dis Colon Rectum 51:1641-8. 2008
    ....
  66. ncbi Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer
    Boone Goodgame
    Division of Medical Oncology, Mallinckrodt Institute of Radiology
    J Thorac Oncol 3:130-4. 2008
    ..We conducted this study to determine whether the preoperative maximum tumor standardized uptake value (SUVmax) was associated with recurrence in patients with resected stage I NSCLC...